The influence of cytokines on the integrity of the blood-brain barrier in vitro

Journal of Neuroimmunology
H E de VriesJ Kuiper

Abstract

The effects of the cytokines tumour necrosis factor-alpha (TNF-alpha), interleukin (IL)-1 beta and IL-6 on the permeability of monolayers of rat cerebral endothelial cells (RCEC) were investigated to assess potential changes in the integrity of the blood-brain barrier (BBB). RCEC were cultured to tight monolayers with a trans endothelial electrical resistance (TEER) of 100-150 ohm . cm2 on polycarbonate filters. Exposure of the RCEC to TNF-alpha, IL-1 beta and IL-6 induced a decline in the TEER, which could be completely abolished by 1 muM of indomethacin, a cyclooxygenase inhibitor. In addition, the effect of IL-1 beta on TEER across monolayers of RCEC could be completely inhibited by IL-1 receptor antagonist. In conclusion, cytokines induce a disruption of the BBB in vitro. In this process, cyclooxygenase activation within the endothelial cells seems to play a key role.

References

Oct 1, 1992·Journal of Neuroimmunology·H P HartungK V Toyka
Jul 1, 1992·Trends in Pharmacological Sciences·M C Morganti-KossmannS M Wahl
Nov 15, 1991·European Journal of Biochemistry·G CamussiF Bussolino
Dec 1, 1991·The Journal of Cell Biology·L L RubinJ Morales
Nov 1, 1991·Trends in Pharmacological Sciences·N J Rothwell
Jan 1, 1991·Neuroscience and Biobehavioral Reviews·C R Plata-Salamán
Mar 1, 1991·Journal of the Neurological Sciences·M MatsudaN Yanagisawa
Jan 1, 1991·Physiological Reviews·M J Kluger
Feb 1, 1990·Current Opinion in Oncology
Dec 1, 1990·Journal of Neuroimmunology·E N BenvenisteG M Fuller
Dec 1, 1990·Immunology Today·T HiranoT Kishimoto
Jan 1, 1985·Progress in Neurobiology·M J Dascombe
Jun 1, 1980·The Journal of Cell Biology·K D McCarthy, J de Vellis
May 16, 1984·Biochemical and Biophysical Research Communications·G G Glenner, C W Wong
May 18, 1994·Biochemical Pharmacology·A C MoorD D Breimer
May 1, 1993·Circulation Research·K C KentJ A Ware

❮ Previous
Next ❯

Citations

Mar 3, 2007·Der Orthopäde·O I SchmidtP F Stahel
Mar 24, 2012·European Journal of Clinical Pharmacology·Takafumi NaitoJunichi Kawakami
May 1, 2009·Acta Neuropathologica·Sukriti NagDuncan J Stewart
May 16, 2013·Cancer Metastasis Reviews·Ming ShiNing Guo
Jul 25, 2009·Cellular and Molecular Neurobiology·Birk PollerHeike Gutmann
Feb 3, 2012·Translational Stroke Research·Adam ChodobskiJoanna Szmydynger-Chodobska
Nov 14, 2000·The American Journal of Pathology·A G BrunelloJ Weis
Oct 22, 2003·Brain Research·Hitoshi KimuraJohn H Zhang
Dec 1, 1999·Psychiatry Research· van Kammen DPJ K Yao
Aug 26, 2003·Advanced Drug Delivery Reviews·Anne M WolkaThomas P Davis
Feb 1, 1997·Progress in Neurobiology·H S Haas, K Schauenstein
Oct 31, 2000·Nutrition·W Langhans
Jan 1, 1997·European Psychiatry : the Journal of the Association of European Psychiatrists·N MüllerM Ackenheil
Jul 24, 1998·Trends in Microbiology·H Smith
Apr 1, 2000·Cytokine & Growth Factor Reviews·E ShohamiJ M Hallenbeck
Feb 11, 2000·Acta Anaesthesiologica Scandinavica·A SablotzkiG Hempelmann
May 8, 2009·Nature·Paula D BosJoan Massagué
Dec 8, 2004·Nature Medicine·Michael S Diamond, Robyn S Klein
Oct 28, 2003·Journal of Neurotrauma·Douglas S DeWitt, Donald S Prough
Aug 24, 1999·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·V TrembovlerE Shohami
Jun 27, 2007·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Ehtishamul HaqInderjit Singh
May 15, 2013·Therapeutic Hypothermia and Temperature Management·Katina ChatzipanteliW Dalton Dietrich
Aug 18, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·William J TricklerSyed F Ali
Jul 17, 2001·The Australian & New Zealand Journal of Obstetrics & Gynaecology·J M Svigos
Mar 8, 2008·Epilepsia·Annamaria VezzaniEleonora Aronica
May 31, 2001·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·W G Mayhan
Aug 14, 1997·Annals of the New York Academy of Sciences·P M Moore
Aug 21, 2007·The Journal of Pharmacology and Experimental Therapeutics·Eduardo Candelario-JalilGary A Rosenberg
Aug 2, 2012·Antimicrobial Agents and Chemotherapy·Liang JinJoseph A Nicolazzo
Jul 16, 2008·Clinical Microbiology Reviews·Abdul MatinNaveed Ahmed Khan
Jul 3, 2009·Journal of Virology·Lisa E GralinskiKatherine R Spindler
Nov 7, 2003·Archives of Disease in Childhood. Fetal and Neonatal Edition·A HeepJ Dembinski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier & Cytokines

Some cytokines are able to cross the blood brain barrier through transport systems and enter the cerebrospinal fluid and interstitial fluid spaces. Here is the latest research on cytokines crossing the blood brain barrier and how this can affect tissues within the CNS.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.